Intrinsic and acquired resistance to methotrexate in acute leukemia Journal Article

  

Authors:	Gorlick, R.; Goker, E.; Trippett, T.; Waltham, M.; Banerjee, D.; Bertino, J. R.
Article Title:	Intrinsic and acquired resistance to methotrexate in acute leukemia
Keywords:	cancer chemotherapy; leukemia; unclassified drug; clinical trial; review; methotrexate; drug resistance; acute leukemia; folinic acid; dihydrofolate reductase; folic acid antagonist; retinoblastoma protein; pemetrexed; drug transport; genes, tumor suppressor; acute disease; blast cell; raltitrexed; trimetrexate; methotrexate derivative; edatrexate; humans; human; priority journal; 2 [5 [[(1,2 dihydro 3 methyl 1 oxobenzo[f]quinazolin 9 yl)methyl]amino] 1 oxo 2 isoindolinyl]glutaric acid; lometrexol; n2 (4 amino 4 deoxy 10 methylpteroyl) n6 (4' fluoresceinthiocarbamoyl)lysine
Journal Title:	New England Journal of Medicine
Volume:	335
Issue:	14
ISSN:	0028-4793
Publisher:	Massachusetts Medical Society
Date Published:	1996-10-03
Start Page:	1041
End Page:	1048
Language:	English
DOI:	10.1056/nejm199610033351408
PUBMED:	8793930
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029846176&doi=10.1056%2fNEJM199610033351408&partnerID=40&md5=c4003fd3ff73f6bb47289d0e45682e8a
Notes:	Review -- Export Date: 22 November 2017 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/123747